 compared to the oral pull arm, that the DSMB feels that it is ethically correct to now stop the randomized phase of the trial and offer the injectable to all the participants. You're saying it's cut short because it's already proved so successful. Correct. Exactly that. So we're moving now into what we call the open label phase, where people can choose to use the injectable, even if they were assigned to the oral pull arm in the trial.